D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The investigators are conducting a randomized double-blind placebo-controlled study to assess
the efficacy of d-cycloserine augmentation of cognitive-behavioral therapy for the treatment
of pediatric obsessive compulsive disorder. This study represents an innovative approach in
translating bench research findings into clinical research and testing a new approach for
optimizing an effective psychotherapy with a safe non-psychotropic medication.